Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Vos

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
JACC. Cardiovascular Interventions|March 7, 2020
Reloading When Switching From Ticagrelor or Prasugrel to Clopidogrel Within 7 Days After STEMIDaniel M F Claassens, Anne H Tavenier, Renicus S Hermanides, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 1, 2006
Long-term results of percutaneous transluminal angioplasty for symptomatic iliac in-stent stenosisR H J Kropman, M Bemelman, J A Vos, et al.
International Journal of Cardiology|September 7, 2017
SMAD4 gene mutation increases the risk of aortic dilation in patients with hereditary haemorrhagic telangiectasiaV M M Vorselaars, A Diederik, V Prabhudesai, et al.
Genes|September 16, 2020
Effect of <i>CYP3A4</i>*22 and <i>PPAR-α</i> Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary InterventionThomas O Bergmeijer, Alfi Yasmina, Gerrit J A Vos, et al.
AJNR. American Journal of Neuroradiology|July 16, 2016
Comparison of CTA- and DSA-Based Collateral Flow Assessment in Patients with Anterior Circulation StrokeI G H Jansen, O A Berkhemer, A J Yoo, et al.
The Journal of Cardiovascular Surgery|November 10, 2012
High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trialJ Van Der Heyden, J Van Werkum, C M Hackeng, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 7, 2021
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics TrialDaniel M F Claassens, Pim W M van Dorst, Gerrit J A Vos, et al.
Circulation. Cardiovascular Interventions|March 16, 2021
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics SubanalysisDaniel M F Claassens, Thomas O Bergmeijer, Gerrit J A Vos, et al.
The New England Journal of Medicine|September 4, 2019
A Genotype-Guided Strategy for Oral P2Y<sub>12</sub> Inhibitors in Primary PCIDaniel M F Claassens, Gerrit J A Vos, Thomas O Bergmeijer, et al.
International Journal of Cardiology|April 22, 2021
Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patientsDaniel M F Claassens, Marieke E Gimbel, Thomas O Bergmeijer, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
JACC. Cardiovascular Interventions|March 7, 2020
Reloading When Switching From Ticagrelor or Prasugrel to Clopidogrel Within 7 Days After STEMIDaniel M F Claassens, Anne H Tavenier, Renicus S Hermanides, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 1, 2006
Long-term results of percutaneous transluminal angioplasty for symptomatic iliac in-stent stenosisR H J Kropman, M Bemelman, J A Vos, et al.
International Journal of Cardiology|September 7, 2017
SMAD4 gene mutation increases the risk of aortic dilation in patients with hereditary haemorrhagic telangiectasiaV M M Vorselaars, A Diederik, V Prabhudesai, et al.
Genes|September 16, 2020
Effect of <i>CYP3A4</i>*22 and <i>PPAR-α</i> Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary InterventionThomas O Bergmeijer, Alfi Yasmina, Gerrit J A Vos, et al.
AJNR. American Journal of Neuroradiology|July 16, 2016
Comparison of CTA- and DSA-Based Collateral Flow Assessment in Patients with Anterior Circulation StrokeI G H Jansen, O A Berkhemer, A J Yoo, et al.
The Journal of Cardiovascular Surgery|November 10, 2012
High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trialJ Van Der Heyden, J Van Werkum, C M Hackeng, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 7, 2021
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics TrialDaniel M F Claassens, Pim W M van Dorst, Gerrit J A Vos, et al.
Circulation. Cardiovascular Interventions|March 16, 2021
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics SubanalysisDaniel M F Claassens, Thomas O Bergmeijer, Gerrit J A Vos, et al.
The New England Journal of Medicine|September 4, 2019
A Genotype-Guided Strategy for Oral P2Y<sub>12</sub> Inhibitors in Primary PCIDaniel M F Claassens, Gerrit J A Vos, Thomas O Bergmeijer, et al.
International Journal of Cardiology|April 22, 2021
Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patientsDaniel M F Claassens, Marieke E Gimbel, Thomas O Bergmeijer, et al.
Pageof 6